Award notice Supplies
Εκαπυ 9/2024 φαρμακα
Notice published in Greek. The AI analysis summarises it for you in your language.
- Public buyer
- Εθνική Κεντρική Αρχή Προμηθειών Υγείας (E.K.A.Π.Υ.)
Αθήνα - Place of performance
- ΑΘΗΝΑ
- Estimated value
- €16,534,905 excl. VAT
- Amount awarded
- €16,534,905 excl. VAT
- Planned end of contract
- 25 September 2029
likely re-tender around March 2029 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 19 October 2026
- Notice language
- Greek
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
ΕΚΑΠΥ 9/2024 ΦΑΡΜΑΚΑ
Awarded to
6 lots
- Α/Α 1 CEFTRIAXONE SODIUM PS.SOL.INF 2G/VIAL
- Α/Α 2 IRINOTECAN HYDROCHLORIDE TRIHYDRATE C/S.SOL.IN 20MG/5ML
- A/A 3 IRINOTECAN HYDROCHLORIDE TRIHYDRATEC/S.SOL.IN20MG/2ML
- Α/Α 4 CARBOPLATIN SOL.INF 150MG/15ML VIAL
- Α/Α 5 AMPICILLIN SODIUM, SULBACTAM SODIUM PD.INJ.SOL (1+2)G/VIAL
- Α/Α 6 SOMATOSTATIN ACETATE PS.SOL.INF 3MG/VIAL
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €129,724
- Median
- €175,195
- A quarter above
- €278,460
Amounts awarded (excl. VAT) over the last 3 years for 37 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 719881-2026.